Naito Mikihiko | 論文著者

Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences

Faculty of Pharmaceutical Sciences, The University of Tokyo

Faculty of Pharmaceutical Sciences, The University of Tokyo|Institute of Applied Microbiology, The Univer-sity of Tokyo

Institute of Applied Microbiology, The University of Tokyo

Institute Of Molecular And Cellular Biosciences The University Of Tokyo

Institute Of Molecular And Cellular Biosciences University Of Tokyo

Institute of Molecular and Cellular Biosciences, The University of Tokyo

Institute of Molecular and Cellular Biosciences, University of Tokyo

Laboratory Of Biomedical Research Institute Of Molecular And Cellular Biosciences The University Of

Laboratory Of Biomedical Research Institute Of Molecular And Cellular Biosciences The University Of

Laboratory Of Biomedical Research Institute Of Molecular And Cellular Biosciences The University Of

Laboratory Of Biomedical Research Institute Of Molecular And Cellular Biosciences The University Of Tokyo

Laboratory of Biomedical Research, Institute of Molecular and Cellular Biosciences, The University o

Laboratory of Biomedical Research, Institute of Molecular and Cellular Biosciences, The University of Tokyo

National Institute Of Health Sciences